OBJECTIVE: To characterize the types of hospices with higher rates of patient disenrollment from the Medicare Hospice Benefit and the markets in which these hospices operate. DATA SOURCE: Secondary analyses of Surveillance, Epidemiology and End Results-Medicare data. Analyses included patients who died of cancer from 1998 to 2002 and who used hospice (n=90,826). STUDY DESIGN: We used generalized estimating equations to estimate the association of patient disenrollment with hospice size, years since Medicare certification, ownership, staff mix, competition, urban/rural status, region, and fiscal intermediary. Other covariates included patient demographic and clinical characteristics. PRINCIPAL FINDINGS: Patients were more likely to disenroll from hospice if they were served by newer hospices (OR=1.14; 95 percent CI 1.03, 1.26), by smaller hospices (OR=1.11; 95 percent CI 1.02, 1.20), or by hospices in more competitive markets (OR=1.17; 95 percent CI 1.03, 1.35). There was an independent effect of the hospice's fiscal intermediary on disenrollment, particularly disenrollment after 6 months with hospice (Wald chi(2)=21.2, p=.007). CONCLUSIONS: The reasons for higher disenrollment rates for newer hospices, for smaller hospices, and for hospices in highly competitive markets are likely complex; however, results suggest that there are organizational-level barriers to keeping patients with cancer enrolled with hospice. Variation across fiscal intermediaries may indicate that regulatory oversight, particularly of long-stay patients, influences hospice disenrollment.
OBJECTIVE: To characterize the types of hospices with higher rates of patient disenrollment from the Medicare Hospice Benefit and the markets in which these hospices operate. DATA SOURCE: Secondary analyses of Surveillance, Epidemiology and End Results-Medicare data. Analyses included patients who died of cancer from 1998 to 2002 and who used hospice (n=90,826). STUDY DESIGN: We used generalized estimating equations to estimate the association of patient disenrollment with hospice size, years since Medicare certification, ownership, staff mix, competition, urban/rural status, region, and fiscal intermediary. Other covariates included patient demographic and clinical characteristics. PRINCIPAL FINDINGS:Patients were more likely to disenroll from hospice if they were served by newer hospices (OR=1.14; 95 percent CI 1.03, 1.26), by smaller hospices (OR=1.11; 95 percent CI 1.02, 1.20), or by hospices in more competitive markets (OR=1.17; 95 percent CI 1.03, 1.35). There was an independent effect of the hospice's fiscal intermediary on disenrollment, particularly disenrollment after 6 months with hospice (Wald chi(2)=21.2, p=.007). CONCLUSIONS: The reasons for higher disenrollment rates for newer hospices, for smaller hospices, and for hospices in highly competitive markets are likely complex; however, results suggest that there are organizational-level barriers to keeping patients with cancer enrolled with hospice. Variation across fiscal intermediaries may indicate that regulatory oversight, particularly of long-stay patients, influences hospice disenrollment.
Authors: Colleen L Barry; Melissa D A Carlson; Jennifer W Thompson; Mark Schlesinger; Ruth McCorkle; Stanislav V Kasl; Elizabeth H Bradley Journal: Med Care Date: 2012-07 Impact factor: 2.983
Authors: Melissa D Aldridge; Mark Schlesinger; Colleen L Barry; R Sean Morrison; Ruth McCorkle; Rosemary Hürzeler; Elizabeth H Bradley Journal: JAMA Intern Med Date: 2014-04 Impact factor: 21.873
Authors: Brystana G Kaufman; David Klemish; Andrew Olson; Cordt T Kassner; Jerome P Reiter; Matthew Harker; Laura Sheble; Benjamin A Goldstein; Donald H Taylor; Nrupen A Bhavsar Journal: J Palliat Med Date: 2019-08-19 Impact factor: 2.947
Authors: Melissa K Accordino; Jason D Wright; Sowmya Vasan; Alfred I Neugut; Tal Gross; Grace C Hillyer; Dawn L Hershman Journal: Breast Cancer Res Treat Date: 2017-07-27 Impact factor: 4.872